technologies available for licensing

Rensselaer Polytechnic Institute has a variety of technologies ranging from chemicals to lighting systems to algorithms and everything in-between. Rensselaer’s technologies can help you start a company or be a great addition to your current technology portfolio. To see what technologies are currently available for licensing at Rensselaer, please use the search below. If you have a technology need that Rensselaer’s technologies don’t currently solve, please reach out to IPO to discuss more your needs.

Use arrow keys to navigate
Displaying 1 - 10 of 25
Behavioral biometrics tools identify users with keystroke dynamics, signature verification, voice recognition, and gesture recognition. These technologies compare a profile of the users against a database created with contextual information, including physiological, cognitive, and contextual traits. Institutions of higher education, governments, and financial institutions use…
Nonphotochemical quenching (NPQ) is a response mechanism in plants and algae that allows them to process and dissipate excess excitation energy as heat safely. Collecting fluorescence data from these plants and algae in surface water environments can incur errors from NPQ, ultimately leading to inaccurate calculations of chlorophyll concentration for environmental and…
Researchers at Rensselaer have created a technology that combines different modules of an LED light fixture into a single component that can be 3D printed. Combining the modules into a single 3D printed component could decrease overall LED light fixture manufacturing/production costs, reduce required labor for product assembly, and reduce the number of parts necessary to…
Unlike vitamin D supplements, phototherapy provides a more natural means of vitamin D production. While research has shown that the vitamin D received from supplements is functionally equivalent to that synthesized from natural sunlight, evidence suggests that vitamin D sourced from sunlight remains active in our bodies longer than vitamin D derived from dietary supplements.…
The SARS-CoV-2 virus continues to cause major issues around the globe. Thus, effective therapeutics are critically needed to help better control the virus. Researchers at RPI and collaborating institutions have identified HCV protease inhibitor drugs that may be viable SARS-CoV-2 antivirals. These researchers have used the 3D structure of the SARS-CoV-2 protease to evaluate…
Intramembrane proteolytic cleavage is an important process in a number of signaling pathways and pathologies. One of the best-known is that of Alzheimer’s Disease (AD), where the gamma-secretase enzyme cleaves amyloid precursor protein (APP) to create free amyloid. This free amyloid accumulates to form amyloid plaques during the later stages of the disease. New drugs are…
Based on the famous ""mfold"", the UNAFold software package is an integrated collection of programs that simulate nucleic acid folding and hybridization, and its melting pathways for one or two single-stranded molecules. The package predicts folding for single-stranded RNA or DNA through combination of free energy minimization, partition function calculations and stochastic…
Rensselaer researchers have developed a scanning electron microscopy based temperature mapping technique which employs a temperature sensitive electron signal for nano-scale resolution, non-contact measurement. It provides enhanced capabilities for investigating heat generation and transfer at the nanoscale to address long-standing issues related to power consumption, heat…
This technology relates to semiconductor devices and growth techniques in the field of III-N semiconductors. For example, the technology provides a semiconductor device with a substrate comprising a groove. A buffer layer is formed on a surface of the groove. The buffer layer has at least one material chosen from AIN, GaN or AlxGa1-xN, where x is between zero and one. An…
This technology relates to visually-guided multiprobe microassembly for assembling micro-electromechanical (MEMS) devices from multiple parts that are assembled rather than using bulk-processes to produce devices monolithically. Current production technologies primarily use a single wafer that is process chemically to produce finished devices. While this is useful for many…